Public Health News Roundup: March 19
Study: One-quarter of Doctors’ Offices Not Equipped for Patients in Wheelchairs
Despite the requirements of the Americans with Disabilities Act, about one quarter of doctors’ offices are not equipped to treat patients in wheelchairs, according to a new study in the Annals of Internal Medicine. The biggest obstacle to treatment was being able to transfer patients to exam tables. “This is affecting a large number of patients, certainly the 3 million who use a wheelchair, but many more than that who have difficulty getting up to an exam table,” said lead author Tara Lagu, an academic hospitalist at Baystate Medical Center in Springfield, Massachusetts, and an assistant professor at Tufts University School of Medicine. “The point of the study is to help doctors realize what the problems are and to help them become more aware of the Americans with Disabilities Act and to identify what the difficulties patients who use wheelchairs are having in accessing health care.” Read more on access to health care.
FDA: Voluntary Recall of Tainted Medical Med Prep Consulting Inc. Products
The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of all products produced by Med Prep Consulting Inc. of Tinton Falls, N.J., after fungus was found in several bags of magnesium sulfate intravenous solution in Connecticut. The magnesium sulfate products may also have been shipped to New Jersey, Pennsylvania and Delaware. While no illness has been reported, FDA is working with the U.S. Centers for Disease Control and Prevention to identify the scope of the contamination. “Giving a patient a contaminated injectable drug could result in a life-threatening infection,” said Janet Woodcock, MD, director of the FDA’s Center for Drug Evaluation and Research. “We do not have reports of patient infections. However, due to a lack of sterility assurance at the facility and out of an abundance of caution, this recall is necessary to protect patients.” Read more on infectious disease.
New Insight into Why Black Kids Receive Fewer Antibiotics
Among all demographics, black children are the least likely to receive antibiotics, according to a new study in the journal Pediatrics. Researchers say this racial disparity in terms of treatment is likely because non-black children are actually over-prescribed the drugs. "The fact that black kids are given fewer antibiotics and fewer broad-spectrum antibiotics may come across as a bad thing to the casual reader, but perhaps it's not an issue of under-treating black kids, but over-treating non-black kids," said Allison Bartlett, MD, a pediatric infectious disease specialist at LaRabida Children's Hospital in Chicago. Read more on prescription drugs.